Answers are grounded in this paper and cite their sources.
Background Hypertension is a rarely recognized complication of acute lymphoblastic leukemia (ALL). The incidence of hypertension in ALL patients in Indonesia remains unknown, but the most common risk factors are corticosteroid use during induction-phase chemotherapy and renal leukemic infiltration.
No takes yet. Share an insight, caveat, or question.
Juliansen et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: